Establishment Labs (NASDAQ:ESTA) Trading Up 4.6% - Still a Buy?

Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report) rose 4.6% on Monday . The stock traded as high as $45.92 and last traded at $45.53. Approximately 106,487 shares were traded during mid-day trading, a decline of 78% from the average daily volume of 474,794 shares. The stock had previously closed at $43.54.

Analyst Upgrades and Downgrades

ESTA has been the subject of several recent analyst reports. Citigroup boosted their price target on Establishment Labs from $38.00 to $47.00 and gave the stock a "neutral" rating in a research note on Wednesday. BTIG Research assumed coverage on Establishment Labs in a research note on Friday, May 16th. They issued a "buy" rating and a $62.00 price target for the company. Wall Street Zen upgraded Establishment Labs from a "sell" rating to a "hold" rating in a research report on Saturday, June 14th. Finally, Needham & Company LLC reiterated a "buy" rating and set a $48.00 price objective on shares of Establishment Labs in a research report on Friday, June 13th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $51.80.

Establishment Labs Stock Performance

The business has a 50-day moving average of $37.98 and a 200 day moving average of $36.97. The company has a debt-to-equity ratio of 5.72, a current ratio of 3.36 and a quick ratio of 2.05. The company has a market cap of $1.33 billion, a PE ratio of -14.83 and a beta of 0.80.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported ($0.70) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.83) by $0.13. Establishment Labs had a negative return on equity of 196.25% and a negative net margin of 52.34%. The business had revenue of $41.38 million during the quarter, compared to analyst estimates of $41.15 million. During the same quarter in the previous year, the company posted ($0.58) earnings per share. Establishment Labs's revenue for the quarter was up 11.3% on a year-over-year basis. Equities research analysts anticipate that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.

Hedge Funds Weigh In On Establishment Labs

A number of hedge funds have recently made changes to their positions in ESTA. Raymond James Financial Inc. bought a new position in shares of Establishment Labs in the fourth quarter worth about $5,494,000. Swiss National Bank boosted its stake in shares of Establishment Labs by 2.7% in the fourth quarter. Swiss National Bank now owns 38,500 shares of the company's stock worth $1,774,000 after acquiring an additional 1,000 shares during the period. Royce & Associates LP bought a new position in Establishment Labs during the fourth quarter valued at approximately $4,862,000. William Blair Investment Management LLC boosted its stake in Establishment Labs by 44.1% during the fourth quarter. William Blair Investment Management LLC now owns 812,825 shares of the company's stock valued at $37,447,000 after buying an additional 248,888 shares during the last quarter. Finally, Sei Investments Co. boosted its stake in Establishment Labs by 22.3% during the fourth quarter. Sei Investments Co. now owns 42,471 shares of the company's stock valued at $1,957,000 after buying an additional 7,731 shares during the last quarter. Institutional investors own 72.91% of the company's stock.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.